Feb 11 (Reuters) - Immutep Limited:
- IMMUTEP GRANTED AUSTRALIAN PATENT FOR EFTILAGIMOD ALPHA, A SOLUBLE LAG-3 PROTEIN, IN COMBINATION WITH A PD-1 PATHWAY INHIBITOR
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $366.9M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 25.0¢ | $149.8K | 588.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 144786 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 294687 | 19 |
View Market Depth
| Last trade - 10.25am 19/09/2025 (20 minute delay) ? |
| IMM (ASX) Chart |